Cerebral to pay nearly $3.7M over controlled substance prescribing practices

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

How to Recognize Tardive Dyskinesia

Differentiating tardive dyskinesia from other movement disorders can be challenging. “One major criterion is the history of exposure to neuroleptic medications,” said Jeff Bronstein, MD,

October 4, 2024

Open Source in Life Sciences: Balancing Innovation and Compliance

Christopher McSpiritt, Head of life sciences at Domino Data Lab Data science teams in the life sciences industry are experiencing a significant change that will

January 10, 2025

Opinion | ‘That’s a Society-Ending Pandemic’: What We Heard This Week

“That’s a society-ending pandemic.” — James Lawler, MD, MPH, of the University of Nebraska Medical Center’s Global Center for Health Security, on viruses with high

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.